Euroapi S.A. (EAPI.PA) Stock
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Euroapi S.A.
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.
Euroapi S.A. is led by CEO David Seignolle, employs 3,000 people, headquartered in Paris, FR, publicly traded since 2022.
over the past 52 weeks the stock has ranged between $0.92 and $3.44, and currently trades 70.9% below its 52-week high.
Official website: www.euroapi.com/en